Navneet Singh Majhail MD , MS, FASTCT

Hematologic Oncology

Physician-in-Chief of Blood Cancers, Sarah Cannon; Director, Sarah Cannon Transplant & Cellular Therapy Program at TriStar Centennial; President (2019), American Society for Transplantation and Cellular Therapy

Join to view full profile

2410 Patterson StSte 500Nashville, TN 37203
Phone+1 615-342-7440

Dr. Majhail is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Majhail's full profile Already have an account?

Education & Training

University of MinnesotaFellowship, Hematology and Medical Oncology, 2004 - 2007
Cleveland Clinic FoundationResidency, Internal Medicine, 2001 - 2004
Government Medical College ChandigrahClass of 1997

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

TN State Medical License 2021 - 2028
NV State Medical License 2023 - 2027
OH State Medical License 2013 - 2022
FL State Medical License 2016 - 2020
MN State Medical License 2006 - 2014
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017

Clinical Trials

The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family
COMPLETED
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RECRUITING
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
RECRUITING
PHASE2

Publications & Presentations

PubMed

Improved outcomes with TKI maintenance after brexucabtagene autoleucel in Philadelphia chromosome ALL.
Tamer Othman, Gregory W Roloff, Katharine Miller, Amy Zhang, Katherine C Sutherland
Blood Advances. 2026-09-08
Regulatory Ambiguity in Hematopoietic Cell Transplantation in India: A National Survey.
M Joseph John, Pankaj Malhotra, Sharat Damodar, Lt Gen Velu Nair, Navneet S Majhail
Transplantation and Cellular Therapy. 2026-08-01
Corrigendum to 'Financial Toxicity, Psychological Well-Being, and Quality of Life in Hematopoietic Stem Cell Transplantation' [Transplantation and Cellular Therapy 31 ...
Daniel A Schaefer, Regina M Longley, Emma D Wolfe, Emma P Keane, Isabella S Larizza
Transplantation and Cellular Therapy. 2026-08-01

Journal Articles

Effect of Bone Marrow CD34+Cells and T-cell Subsets on Clinical Outcomes After Myeloablative Allogeneic Hematopoietic Cell Transplantation
Deepa Jagadeesh, Matt Kalaycio, Brian Bolwell, Betty K Hamilton, Brian Hill, Brad Pohlman, Robert Dean, Navneet S Majhail, Sagar S Patel, Rabi Hanna, Aaron T Gerds, Ro..., Nature

Abstracts/Posters

Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...
Navneet S. Majhail, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis
Navneet S. Majhail, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Inotuzumab Ozogamicin Post-Transplant for Acute Lymphocytic Leukemia
Navneet S. Majhail, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

How to Set up a Health Services and Outcomes Research Program
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Career-Development Lunch Sessions: Adult Clinical Malignant Hematology/BMT
60th American Society of Hematology Annual Meeting - 12/1/2018
Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Authored Content

Standardization of Outpatient Care After CAR-T Therapy Across a Large Cell Therapy Network- Through Technology and Decentralized Virtual Nurses: Preliminary ResultsDecember 2023

Press Mentions

Navneet Majhail Named Deputy Physician-in-Chief of Blood Cancers at Sarah CannonJune 25th, 2021
A Deep Dive into HLA Typing for Unrelated Donor Hematopoietic Cell TransplantationMay 20th, 2021
Piner Man Is Cleveland Clinic's First MS Patient for Special TreatmentFebruary 28th, 2021